Announced details
Acute spinal cord injury and severe cervical spinal cord injury
The results of clinical trials conducted by the Company will be presented at the annual meeting. Capital, personnel and business relationships: Not disclosed.
An academic society that organizes academic meetings in the field of orthopaedic surgery. Other details: Not disclosed.
Kobe Convention Center (Kobe, Hyogo Prefecture)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Miyakoshi N et al. Spinal Cord 2021 Jun;59(6):626-634.
Shingu Hikosuke (新宮彦助), “Prevention of Spinal Cord Injury,” Journal of the Japanese Paraplegia Medical Society 13:48-49, 2000
Sakai Hiroaki (坂井宏旭), “Epidemiological Survey,” Comprehensive Rehabilitation 36:969-972, 2008
| Item | Details |
|---|---|
| Names of Products / Services Covered | Recombinant human HGF protein product (development code: KP-100IT) |
| Counterparty | Japanese Orthopaedic Association |
| Counterparty overview | An academic society that organizes academic meetings in the field of orthopaedic surgery. Other details: Not disclosed. |
| Relationship with the Company | The results of clinical trials conducted by the Company will be presented at the annual meeting. Capital, personnel and business relationships: Not disclosed. |
| Launch date | 23 May 2026 (scheduled presentation) |
| Applicable area | Acute spinal cord injury and severe cervical spinal cord injury |
| Location | Kobe Convention Center (Kobe, Hyogo Prefecture) |
| Source | Miyakoshi N et al. Spinal Cord 2021 Jun;59(6):626-634., Shingu Hikosuke (新宮彦助), “Prevention of Spinal Cord Injury,” Journal of the Japanese Paraplegia Medical Society 13:48-49, 2000, Sakai Hiroaki (坂井宏旭), “Epidemiological Survey,” Comprehensive Rehabilitation 36:969-972, 2008 |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the results of the clinical data analysis at the annual meeting and provide more comprehensive insights into the efficacy and clinical positioning of HGF therapy for severe cervical spinal cord injury.